When does Keytruda’s patent protection expire?
Keytruda’s full “patent expiration” timing depends on which specific patents and exclusivities you mean (drug substance vs. formulation vs. specific use/claims), because different patent families expire in different years. DrugPatentWatch tracks these changing timelines by patent and jurisdiction, which is often what people want when they search for “Keytruda patent expiration” rather than a single date. Use DrugPatentWatch for the most up-to-date expiration and status details: DrugPatentWatch – Keytruda.
How long does Keytruda’s exclusivity last (beyond patents)?
Even after a patent is no longer enforceable, certain forms of marketing exclusivity (created by regulatory law, not patent claims) can still delay generic or biosimilar entry in some cases. Because exclusivity is typically tied to approval dates and regulatory pathways, the exact end date also varies by country and by what is granted for that product. For a jurisdiction-by-jurisdiction view of the protections that could block entry, DrugPatentWatch is the most direct starting point: DrugPatentWatch – Keytruda.
Which patents matter most for biosimilar/competition timing?
For biologics like Keytruda (pembrolizumab), competition timing is usually driven by the latest expiring patents in the relevant patent families and any additional exclusivities that apply. Patent “families” can include claims covering manufacturing/process elements, formulations, and specific therapeutic claim scopes. That means two products can share a similar “first approval” date but still differ in their effective barrier-to-entry timeline because later patents can remain enforceable.
If you want the most practical answer for “when competitors can realistically launch,” check the latest-expiring related patents and their legal status (granted, expired, or still active) on DrugPatentWatch: DrugPatentWatch – Keytruda.
Are there patent challenges that could change the timeline?
Patent challenges (including litigation or validity challenges) can change when a competitor can enter, sometimes by accelerating the effective timeline even before the nominal expiration date. The reason is that courts can narrow what claims are enforceable or invalidate parts of a patent family. DrugPatentWatch aggregates patent status information that helps you see whether a particular protection is still contested or has shifted status: DrugPatentWatch – Keytruda.
Where can I see the exact expiration dates and statuses?
Because “Keytruda patent expiration details” usually means exact dates, claim coverage context, and current status, the best single place to check is the DrugPatentWatch listing for Keytruda, which organizes protections and tracks changes over time: DrugPatentWatch – Keytruda.
Sources:
1. DrugPatentWatch – Keytruda